Catalog No.:AA00DB5R

503614-91-3 | Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylate

Name: Name:Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylate
Brand: AABLOCKS
SKU: AA00DB5R
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

250mg

97%

in stock

$9.00 $7.00

- +

97%

in stock

$22.00 $15.00

- +

97%

in stock

$38.00 $27.00

- +

25g

97%

in stock

$175.00 $123.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA00DB5R

Chemical Name:

Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylate

CAS Number:

503614-91-3

Molecular Formula:

C27H28N4O5

Molecular Weight:

488.5350

MDL Number:

MFCD18072444

SMILES:

CCOC(=O)c1nn(c2c1CCN(C2=O)c1ccc(cc1)N1CCCCC1=O)c1ccc(cc1)OC

Properties

Computed Properties

Complexity:

808

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Rotatable Bond Count:

XLogP3:

3.6

Downstream Synthesis Route

675-20-7

473927-64-9

503614-91-3

[1]Patent:WO2015/111073,2015,A3.Locationinpatent:Page/Pagecolumn12

[2]Patent:WO2012/168364,2012,A1.Locationinpatent:Page/Pagecolumn18-19

[3]Patent:WO2010/30983,2010,A2.Locationinpatent:Page/Pagecolumn31-32

[4]Patent:US2017/50964,2017,A1.Locationinpatent:Paragraph0885

[5]JournalofMedicinalChemistry,2007,vol.50,p.5339-5356

[6]Patent:WO2014/75648,2014,A1.Locationinpatent:Page/Pagecolumn12

[7]Patent:WO2015/177801,2015,A1.Locationinpatent:Page/Pagecolumn26;27

503614-91-3

apixaban

[1]Patent:CN107936015,2018,A.Locationinpatent:Paragraph0007;0011;0039-0040;0046-0047;0053-0054;0060

[2]Patent:CN106117201,2016,A.Locationinpatent:Paragraph00312;0032;0033;0034;0035;0036;0037-0060

[3]Patent:CN104628724,2017,B.Locationinpatent:Paragraph0029;0030;0033;0034;0037;0038;0041;0042

[4]SyntheticCommunications,2013,vol.43,p.72-79

[5]Patent:CN106117200,2016,A.Locationinpatent:Paragraph0028;0046;0047;0048

[6]Patent:US2017/15663,2017,A1.Locationinpatent:Paragraph0149

[7]Patent:CN109627242,2019,A.Locationinpatent:Paragraph0035-0038;0041-0044

[8]Patent:WO2014/75648,2014,A1.Locationinpatent:Page/Pagecolumn15

[9]Patent:CN105254630,2016,A.Locationinpatent:Paragraph0061;0062;0063

[10]Patent:CN104892601,2017,B.Locationinpatent:Paragraph0020;0050-0051

[11]Patent:CN103694237,2016,B.Locationinpatent:Paragraph0120-0122

[12]Patent:US2017/313695,2017,A1.Locationinpatent:Paragraph0069

[13]Patent:WO2017/187245,2017,A1.Locationinpatent:Page/Pagecolumn14

[14]JournalofMedicinalChemistry,2007,vol.50,p.5339-5356

[15]Patent:WO2012/168364,2012,A1.Locationinpatent:Page/Pagecolumn19-20

[16]BioorganicandMedicinalChemistry,2016,vol.24,p.5646-5661

[17]BioorganicandMedicinalChemistry,2017,vol.25,p.2800-2810

[18]Patent:WO2014/72884,2014,A1.Locationinpatent:Page/Pagecolumn11

[19]Patent:CN107400131,2017,A.Locationinpatent:Paragraph0031;0057-0059

[20]Patent:CN107955002,2018,A.Locationinpatent:Paragraph0114;0117

[21]Patent:US2017/50964,2017,A1.Locationinpatent:Paragraph0751

[22]Patent:WO2015/111073,2015,A3.Locationinpatent:Page/Pagecolumn13

[23]Patent:WO2010/30983,2010,A2.Locationinpatent:Page/Pagecolumn32

[24]Patent:WO2013/119328,2013,A1.Locationinpatent:Paragraph0050

[25]Patent:WO2014/111954,2014,A1.Locationinpatent:Paragraph0135

[26]Patent:WO2015/162551,2015,A1.Locationinpatent:Page/Pagecolumn16-17

[27]Patent:WO2015/177801,2015,A1.Locationinpatent:Page/Pagecolumn27

[28]Patent:WO2016/20711,2016,A1

[29]Patent:WO2016/20711,2016,A1

[30]Patent:US2015/353541,2015,A1.Locationinpatent:Paragraph0135

[31]Patent:CN103896940,2016,B

[32]Patent:WO2017/13079,2017,A1.Locationinpatent:Paragraph00188

[33]Patent:CN104045637,2016,B

[34]MonatsheftefurChemie,2017,vol.148,p.1477-1482

[35]Patent:US2016/326171,2016,A1.Locationinpatent:Paragraph0183;0184

[36]Patent:US2016/326171,2016,A1

[37]Patent:US2016/326171,2016,A1

[38]Patent:US2016/326171,2016,A1

503614-91-3

75-24-1

109-81-9

503612-86-0

[1]Patent:US2003/191115,2003,A1

chloro((4-methoxyphenyl)hydrazonoaceticacidethylester

545445-44-1

503614-91-3

[1]Patent:US2003/181466,2003,A1

503614-91-3

503612-88-2

[1]Patent:US2003/191115,2003,A1

[2]Patent:US2017/50964,2017,A1

[3]Patent:US2017/50964,2017,A1

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS